Hypercholesterolemia: Clinical Trials

2 trials for Hypercholesterolemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Enrolling by invitation 2

Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
lerodalcibep 300 mg Monthly SC - Familial Hypercholesterolemia - Heterozygous
Phase 3Enrolling by invitationLIB Therapeutics LLC1502026-07-202026-07-28
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
lerodalcibep - Cardiovascular Disease With Mention of Arteriosclerosis, Elevated Cholesterol
Phase 3Enrolling by invitationLIB Therapeutics LLC20002020-12-032024-10-22

Narrower conditions

Hyperlipoproteinemia Type II (1)

Broader conditions

Dyslipidemias (2)  ·  Hyperlipidemias (2)  ·  Lipid Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hyperlipoproteinemias (1)  ·  Lipid Metabolism, Inborn Errors (1)  ·  Metabolism, Inborn Errors (1)

Sponsors

LIB Therapeutics LLC (2)

Countries

Israel (2)  ·  Norway (2)  ·  South Africa (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  India (1)  ·  New Zealand (1)

Top investigators

David Kallend, MB BCh (1)  ·  David Kallend, MB BS (1)

Results publications

PMID 42054033

NIH funding

2025 (1)